Riabkova M G, Tsypin L E, Grebennikov V A, Everstova T N, Vorontsova N Iu, Pak T A
Anesteziol Reanimatol. 2010 Jan-Feb(1):34-7.
The efficacy of the breast milk fortifier Friso versus breastfeeding only was studied in premature very low birthweight babies without congenital malformations. Product tolerability, blood biochemical parameters, physical developmental indices, and the length of respiratory support and intensive care unit (ICU) stay were estimated. Twenty-seven infants at 36 weeks post-conception age were followed up. Fortifier supplementation was found to improve physical development indices (body weight and head and chest circumferences) in the first month of life. Energy feeding output reduced the length of ICU stay and the time of parenteral feeding.
在无先天性畸形的早产极低出生体重儿中,研究了母乳强化剂弗里索(Friso)与单纯母乳喂养的效果。评估了产品耐受性、血液生化参数、身体发育指标以及呼吸支持时间和重症监护病房(ICU)住院时间。对27名孕龄36周的婴儿进行了随访。结果发现,补充强化剂可改善出生后第一个月的身体发育指标(体重、头围和胸围)。能量喂养量减少了ICU住院时间和肠外喂养时间。